Asset Details
Do you wish to reserve the book?
Hematopoietic stem cell transplantation activity in Europe 1999
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hematopoietic stem cell transplantation activity in Europe 1999
Do you wish to request the book?
Hematopoietic stem cell transplantation activity in Europe 1999
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hematopoietic stem cell transplantation activity in Europe 1999
2001
Overview
This survey on transplantation of hematopoietic stem cells from blood or bone marrow in Europe, the 10th in a series, reports the numbers of transplants performed in 1999 and concentrates on changes in indications and donor types. Members of the European Group for Blood and Marrow Transplantation and associated teams are invited every year to report their transplant numbers by indication, donor type and stem cell source. In 1999, a total 21 430 transplants were performed by 580 teams in 35 European countries. Of these transplants 18 720 were first transplants, 5879 (31%) allogeneic, 12 841 (69%) autologous; an additional 562 allogeneic and 2148 autologous transplants were re- or multiple transplants. Ninety-five percent of the autologous transplants and 45% of the allogeneic transplants were peripheral blood stem cell transplants. A total of 103, respectively 1.8% of the allogeneic transplants, were cord blood cell transplants. Main indications in 1999 were leukemias with 6289 transplants (34%), 70% thereof allogeneic transplants; lymphomas with 8219 transplants (44%), 92% thereof autologous transplants; solid tumors with 3302 transplants (18%), 99% thereof autologous transplants; nonmalignant disorders with 715 transplants (4%), 85% thereof allogeneic transplants. Absolute numbers of allogeneic transplants continued to increase as in previous years by 10%, in contrast, there was for the first time in 10 years a decrease in autologous transplants, mainly for solid tumors. Reasons therefore are discussed. These data reflect the most recent changes in utilisation and document current status of blood and marrow transplantation in Europe.
Publisher
Nature Publishing Group
Subject
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
/ Biological and medical sciences
/ Blood
/ Bone marrow, stem cells transplantation. Graft versus host reaction
/ Europe
/ Hematopoietic Stem Cell Transplantation - statistics & numerical data
/ Hematopoietic Stem Cell Transplantation - trends
/ Hematopoietic Stem Cell Transplantation - utilization
/ Humans
/ Leukemia
/ Lymphoma
/ Teams
/ Transfusions. Complications. Transfusion reactions. Cell and gene therapy
/ Transplantation, Autologous - utilization
/ Transplantation, Homologous - utilization
/ Tumors
